Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FBIO stock hub

Fortress Biotech, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

79.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

FBIO

In the news

Latest news · FBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-108.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-43.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001429260
Company name	Fortress Biotech, Inc.
Country	United States
Country code	US
Cusip	34960Q109
Employees	78
Employees Change	-23%
Employees Change Percent	-22.77
Enterprise value	$67.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US34960Q3074
Last refreshed	2026-05-10
Market cap	$79.4M
Market cap category	Micro-Cap
Price	$2.39
Price currency	USD
Rev Per Employee	811,051.28x
Sector	Healthcare
Sic	2834
Symbol	FBIO
Website	https://www.fortressbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.37%
EV Sales Forward	0.81x
EV/Sales	1.06x
FCF yield	-82.85%
P/B ratio	1.5x
P/S ratio	1.26x
PS Forward	0.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-111%
EBITDA Margin	-103.63%
Gross margin	48.11%
Gross Profit	$30.4M
Gross Profit Growth Q	2,101.2%
Net Income	$-1.9M
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Pretax Margin	-53.01%
Profit Margin	10.77%
Profit Per Employee	$-24,128
ROA	-26.62
Roa5y	-34.74
ROCE	-51.71
ROE	-108.7
ROIC	-43.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-25.39%
Cagr1y	38.98%
Cagr3y	-39.85%
Cagr5y	-47.36%
EPS Growth Quarters	11
EPS Growth Years	3
Revenue Growth	9.69x
Revenue Growth Q	6.34x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-5.83x
Revenue Growth5 Y	6.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.38
Assets	$185.5M
Cash	$79.4M
Current Assets	$123.8M
Current Liabilities	$49.7M
Debt	$67.2M
Debt Equity	$1.08
Equity	$62.2M
Interest Coverage	-6.95
Liabilities	$123.4M
Long Term Assets	$61.7M
Long Term Liabilities	$73.6M
Net Cash	$12.2M
Net Cash By Market Cap	$15.32
Net Debt Equity	$-0.2
Tangible Book Value	$22.3M
Tangible Book Value Per Share	$0.71
WACC	11.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.49
Inventory Turnover	2.73
Net Working Capital	$-3.2M
Quick ratio	2.2
Working Capital	$74.1M
Working Capital Turnover	$1.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.65%
1Y total return	38.95%
200-day SMA	2.92
3Y total return	-78.25%
50-day SMA	2.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.96%
All Time High	190.5
All Time High Change	-98.75%
All Time High Date	2013-04-23
All Time Low	1.24
All Time Low Change	92.74%
All Time Low Date	2023-11-10
ATR	0.13
Beta	1.16
Beta1y	0.45
Beta2y	0.84
Ch YTD	-34.7
High	2.44
High52	4.53
High52 Date	2026-01-09
High52ch	-47.24%
Low	2.36
Low52	1.6
Low52 Date	2025-05-13
Low52ch	49.38%
Ma50ch	-11.51%
Premarket Change Percent	2.08
Premarket Price	$2.45
Premarket Volume	561
Price vs 200-day SMA	-18.23%
RSI	45.92
RSI Monthly	40.89
RSI Weekly	39.79
Sharpe ratio	0.77x
Sortino ratio	1.23
Total Return	-34.25%
Tr YTD	-34.7
Tr1m	1.7%
Tr1w	2.58%
Tr3m	-26.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	16,338,000x
Earnings Revenue Estimate Growth	24.35x
Operating Income	$-70.2M
Operating margin	-111
Price target	$17
Price Target Change	$611

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,090,599%
Float Percent	69.51%
Net Borrowing	-700,000
Shares Insiders	22.26%
Shares Institutions	18.13%
Shares Out	33,219,072
Shares Qo Q	-8.21%
Shares Yo Y	34.25%
Short Float	19.69%
Short Ratio	8.89
Short Shares	13.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-94.5M
Average Volume	262,320.65x
Bv Per Share	1.59
Ch10y	-94.65
Ch1m	1.7
Ch1w	2.58
Ch1y	38.95
Ch3m	-26.91
Ch3y	-78.25
Ch5y	-95.96
Ch6m	-8.43
Change	-0.42%
Change From Open	-2.05
Close	2.4
Days Gap	1.67
Depreciation Amortization	4,661,000
Dollar Volume	232,422.7
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-70.2M
EBITDA	$-65.6M
EPS	$-0.07
F Score	4
FCF	$-65.8M
FCF EV Yield	-97.84x
FCF Per Share	$-1.98
Financing CF	77,442,000
Fiscal Year End	December
Founded	2,006
Income Tax	$-620,000
Investing CF	10,121,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2023-10-10
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	2.99
Ma150ch	-20.01%
Ma20	2.34
Ma20ch	1.96%
Net CF	21,786,000
Next Earnings Date	2026-05-22
Open	2.44
Optionable	Yes
Position In Range	37.5
Post Close	2.39
Postmarket Change Percent	4.6
Postmarket Price	$2.5
Ppne	14,821,000
Pre Close	2.4
Price Date	2026-05-08
Ptbv Ratio	3.57
Relative Volume	0.37x
Revenue	63,262,000x
SBC By Revenue	45.43x
Share Based Comp	28,739,000
Tax By Revenue	-0.98x
Tr6m	-8.43%
Us State	Florida
Volume	97,248
Z Score	-5.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FBIO pay a dividend?

Capital-return profile for this ticker.

Performance

FBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.1%

Float: +69.5% of shares outstanding

Insider ownership

+22.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.9

Neutral momentum band

Price vs 200-day MA

-18.2%

50/200-day relationship not available

Beta (5Y)

1.16

Moves roughly with the market

Sharpe ratio

0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current FBIO stock rating?

Fortress Biotech, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full FBIO analysis?

The full report lives at /stocks/FBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for FBIO?

The latest report frames FBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the FBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.